Keywords: GOLD; 3-ADON; 3-acetyldeoxynivalenol; 15-ADON; 15-acetyldeoxynivalenol; AFs; aflatoxins; ANOVA; analysis of variance; AUR; aurofusarin; BEA; beauvericin; BIK; bikaverin; BUT; butenolide; CULM; culmorin; DON; deoxynivalenol; DON-3-G; deoxynivalenol-3-glucoside;
مقالات ISI GOLD (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: GOLD; AGS; aerobic granular sludge; AUR; ammonium utilization rate; BOD5; biochemical oxygen demand; COD; chemical oxygen demand; EPS; extracellular polymeric substances; F/M; food vs microorganism ratio; FAS; flocculent activated sludge; HRT; hydraulic retenti
Keywords: GOLD; 3-SLS; three-stage least square; AGM; annual general meetings; ASX; Australian Securities Exchange; AUR; asset utilisation ratio; BCCI; bank of credit and commerce international; CEO; Chief Executive Office; CGN; Corporate Governance Notification; CLERP;
Keywords: GOLD; Litter decomposition; Nutrient deposition; AUR; Phosphorus limitation; Nitrogen addition; Microbial enzymatic activity;
Keywords: GOLD; Program coordinator; program manager; program management; change agent; manage up; quality improvement; data analyst; data analysis; professional development; GME; ACGME; AUR; APCR;
Sequential enzymatic derivatization coupled with online microdialysis sampling for simultaneous profiling of mouse tumor extracellular hydrogen peroxide, lactate, and glucose
Keywords: GOLD; Enzymatic derivatization; Glucose; Hydrogen peroxide; Lactate; Tumor extracellular fluid; ABTS; 2,2â²-azino-bis(3-ethyl-benzthiazoline-6-sulfonic acid); DCFH; 2â²,7â²-dichlorodihydrofluorescein; TMB; 3,3â²,5,5â²-tetramethylbenzidine; AUR; Amplex® Ul
Keywords: GOLD; ablation techniques; high-intensity focused ultrasound ablation; prostatic neoplasms; ADT; androgen deprivation therapy; AUR; acute urinary retention; BCR; biochemical recurrence; ED; erectile dysfunction; EORTC; European Organization for Research and Tre
Keywords: GOLD; 3-ADON; 3-acetyldeoxynivalenol; 15-ADON; 15-acetyldeoxynivalenol; AME; alternariol methyl ether; AOH; alternariol; ANOVA; analysis of variance; AUR; aurofusarin; BEA; beauvericin; BIK; bikaverin; BUT; butenolide; CHRY; chrysogine; CULM; culmorin; DEC; dec
Keywords: GOLD; AR; Androgen Receptor; BPH; Benign Prostatic Hyperplasia; LUTS; Lower Urinary Tract Symptoms; PVR; Post-Void Residual; AUR; Acute Urinary Retention; AUASS; American Urological Association Symptom Score; PSA; Prostate Specific Antigen; 5ARI; 5 Alpha Reduct
Keywords: GOLD; prostatic hyperplasia; arteries; embolization; therapeutic; treatment outcome; therapies; investigational; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; CT; clinical trial; IIEF; International Index of Erectile Function; ITT; intent to
Keywords: GOLD; prostatic hyperplasia; catheter-related infections; urinary tract infections; urinary retention; urinary catheters; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; CAUTI; catheter associated urinary tract infection; IUC; indwelling urinar
Keywords: GOLD; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; CI; confidence interval; DSA; Digital subtraction angiography; IIEF; International Index of Erectile Function; IPSS; International Prostate Symptom Score; LUTS; lower urinary tract symptoms;
Keywords: GOLD; prostate; prostatic hyperplasia; urinary retention; inflammation; disease progression; AUR; acute urinary retention; BMI; body mass index; BPE; benign prostatic enlargement; BPH; benign prostatic hyperplasia; LUTS; lower urinary tract symptoms; PSA; prost
Keywords: GOLD; acute urinary retention; AUR; bladder; dermoid cyst; mature cystic teratoma; ovarian teratoma; ovary; pediatric urinary retention; teratoma; urethra; urinary retention;
A comparative study on the effects of acute and chronic downhill running vs uphill running exercise on the RNA levels of the skeletal muscles PGC1-α, FNDC5 and the adipose UCP1 in BALB/c mice
Keywords: GOLD; ACtrl; acute control without exercise; ADR; acute downhill running; AUR; acute uphill running; AWI; acute running without inclination; CCtrl; chronic control without exercise; CDR; chronic downhill running; CON; concentric; CUR; chronic uphill running; CW
Time- and cell-resolved dynamics of redox-sensitive Nrf2, HIF and NF-κB activities in 3D spheroids enriched for cancer stem cells
Keywords: GOLD; AUR; auranofin; CA9; carbonic anhydrase IX; CDKN1B; cyclin-dependent kinase inhibitor 1B (p27); CSC; cancer stem cell; DMOG; dimethyloxalylglycine; GSH; glutathione; HIF; hypoxia inducible factor; MUC2; mucin2; NCL; nucleolin; NFE2L2 or Nrf2; nuclear fact
Can androgen-deprivation therapy obviate the need of channel transurethral resection of the prostate in advanced prostate cancer with urinary retention? A prospective study
Keywords: GOLD; ADT; androgen-deprivation therapy; AUR; acute urinary retention; pTURP; palliative TURP; TWOC; trial of voiding without catheter; USG KUB; ultrasonography of the kidney, ureter and bladder; ADT; ADT in retention; Prostate cancer;
QSAR models for thyroperoxidase inhibition and screening of U.S. and EU chemical inventories
Keywords: GOLD; QSAR; Thyroperoxidase (TPO) inhibition; Adverse Outcome Pathway (AOP); Screening; BHA; REACH; AD; applicability domain; AOP; adverse outcome pathway; AUR; Amplex®UltraRed; BHA; butylated hydroxyanisole; DNT; developmental neurotoxicity; DTU Food; Technic
Prostate Embolization as an Alternative to Open Surgery in Patients with Large Prostate and Moderate to Severe Lower Urinary Tract Symptoms
Keywords: GOLD; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; CI; confidence interval; HoLEP; holmium laser enucleation of the prostate; IIEF; International Index of Erectile Function; IPSS; International Prostate Symptom Score; LUTS; lower urinary tra
Diazoxide enhances excitotoxicity-induced neurogenesis and attenuates neurodegeneration in the rat non-neurogenic hippocampus
Keywords: GOLD; AUR; arbitrary uniform random; BrdU; bromo-deoxyuridine; CNS; central nervous system; DAB; diaminobenzidine; DG; dentate gyrus; DCX; doublecortin; DMSO; dimethyl sulfoxide; Dzx; diazoxide; GFAP; glial fibrillary acidic protein; HF; hippocampal formation;
The thioredoxin and glutathione-dependent H2O2 consumption pathways in muscle mitochondria: Involvement in H2O2 metabolism and consequence to H2O2 efflux assays
Keywords: GOLD; AUR; Amplex UltraRed; HRP; horseradish peroxidase; NNT; nicotinamide nucleotide transhydrogenase; PMF; protonmotive force; Trx; thioredoxin; CDNB; 1-chloro-2,4-dintrobenzene; FCCP; carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone; 2-AAPA; 2-acetylami
Treatment of sewage sludge in a thermophilic membrane reactor (TMR) with alternate aeration cycles
Keywords: GOLD; Sludge adaptation; Sludge minimization; Aeration/non aeration cycles; Membrane biological reactor (MBR); AUR; ammonia uptake rate; CAS; conventional activated sludge; COD; chemical oxygen demand; EPS; extracellular polymeric substance; HRT; hydraulic rete
Prostatic Artery Embolization to Treat Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia and Bleeding in Patients with Prostate Cancer: Proceedings from a Multidisciplinary Research Consensus Panel
Keywords: GOLD; AUR; acute urinary retention; BOO; bladder outlet obstruction; BPH; benign prostatic hyperplasia; FDA; U.S. Food and Drug Administration; IDE; investigational device exemption; IPSS; International Prostate Symptom Score; LUTS; lower urinary tract symptoms
Benign Prostate Specific Antigen Distribution and Associations With Urological Outcomes in Community Dwelling Black and White Men
Keywords: GOLD; prostate; prostatic hyperplasia; prostate-specific antigen; prostatic neoplasms; continental population groups; AUA; American Urological Association; AUASI; AUA symptom index; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; BPSA; benign P
Influence of Dose on Risk of Acute Urinary Retention After Iodine-125 Prostate Brachytherapy
Keywords: GOLD; Acute urinary retention; AUR; Urinary toxicity; Prostate cancer; Prostate brachytherapy; Dose;
Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors
Keywords: GOLD; DTNB, dithionitrobenzoic acid; DTT, dithiothreitol; TrxR, thioredoxin reductase; TrxR1, cytosolic thioredoxin reductase; TrxR2, mitochondrial thioredoxin reductase; Trx1, cytosolic thioredoxin; Trx2, mitochondrial thioredoxin; PAO, phenylarsine oxide; aur
Descending projections to the hindbrain and spinal cord in the paddlefish Polyodon spathula
Keywords: GOLD; aur; auricles; BDA; biotinylated dextran amine; bo; bulbus olfactorius; cer; cerebellum; cpth; central posterior thalamic nucleus; DAB; diaminobenzidine; don; dorsal octavolateral nucleus; dpth; dorsal posterior thalamic nucleus; fr; fasciculus retroflexu
Efficacy and Safety of Extended-Release Oxybutynin in Combination With Tamsulosin for Treatment of Lower Urinary Tract Symptoms in Men: Randomized, Double-Blind, Placebo-Controlled Study
Keywords: GOLD; AE; adverse event; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; BPO; benign prostatic obstruction; GRA; global response assessment; IPSS; International Prostate Symptom Score; ITT; intention-to-treat; LOCF; last observation carried for
Intravesical Prostatic Protrusion is Better Than Prostate Volume in Predicting the Outcome of Trial Without Catheter in White Men Presenting With Acute Urinary Retention: A Prospective Clinical Study
Keywords: GOLD; urinary retention; catheterization; organ size; treatment outcome; prognosis; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; DRE; digital rectal examination; IPP; intravesical prostatic protrusion; PV; prostate volume; TRUS; transrectal
Highlights From the Combined Society of Urodynamics and Female Urology, and International Society of Pelvic Neuromodulation Annual Meeting
Keywords: GOLD; congress; urodynamics; urinary incontinence; female; prostate; AUR; acute urinary retention; AUS; artificial urinary sphincter; DO; detrusor overactivity; EAE; experimental autoimmune encephalitis; IC; interstitial cystitis; I-PSS; International Prostate
Examination of the Relationship Between Symptoms of Prostatitis and Histological Inflammation: Baseline Data From the REDUCE Chemoprevention Trial
Keywords: GOLD; prostate; biopsy; inflammation; urination disorders; prostatitis; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; CP; chronic prostatitis; CPPS; chronic pelvic pain syndrome; CPSI; CP Symptom Index; EPS; expressed prostatic secretions; NI
Post-Void Residual Urine Volume is Not a Good Predictor of the Need for Invasive Therapy Among Patients With Benign Prostatic Hyperplasia
Keywords: GOLD; prostatic hyperplasia; adrenergic alpha-antagonists; treatment outcome; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; I-PSS; International Prostate Symptom Score; PSA; serum prostate specific antigen; PV; prostate volume; PVR; post-void
Incidence of Primary and Recurrent Acute Urinary Retention Between 1998 and 2003 in England
Keywords: GOLD; prostate; prostatectomy; prostatic hyperplasia; urinary retention; epidemiology; AUR; acute urinary retention; BPH; benign prostatic hyperplasia; HES; Hospital Episode Statistics; ICD-10; International Classification of Diseases, Tenth Revision; NHS; Nati
Risk Assessment and Medical Management of Acute Urinary Retention in Patients with Benign Prostatic Hyperplasia
Keywords: GOLD; Benign prostatic hyperplasia; BPH; Natural history; Risk factors; Acute urinary retention; AUR; Trial without catheter; TWOC
Low Incidence of Acute Urinary Retention in the General Male Population: The Triumph Project
Keywords: GOLD; AUR; acute urinary retention; LUTS/BPH; lower urinary tract symptoms suggestive of benign prostatic hyperplasia; BPH; benign prostatic hyperplasia; 95%CI; 95% confidence intervals; Benign prostatic hyperplasia; Urinary retention; Urinary symptoms; Cohort